{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:15:38Z","timestamp":1793301338871,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004497","name":"Onderzoeksraad, KU Leuven","doi-asserted-by":"publisher","award":["C14\/22\/074"],"award-info":[{"award-number":["C14\/22\/074"]}],"id":[{"id":"10.13039\/501100004497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11A6320N"],"award-info":[{"award-number":["11A6320N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1SH8H24N"],"award-info":[{"award-number":["1SH8H24N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1S51718N"],"award-info":[{"award-number":["1S51718N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006282","name":"Koning Boudewijnstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jconrel.2025.114027","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:57:36Z","timestamp":1752580656000},"page":"114027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Efficacy versus immunogenicity of LNP-mediated delivery of mRNA and self-amplifying RNA upon intravitreal injection in the mouse eye"],"prefix":"10.1016","volume":"385","author":[{"given":"Weiran","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Vanluchene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Raes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Peynshaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Veys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda Gonz\u00e1lez","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"De Lombaerde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno G.","family":"De Geest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niek N.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"Moons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Raemdonck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lies","family":"De Groef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Remaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114027_bb0005","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study","volume":"9","author":"Blindness, G. B. D., Vision Impairment, C. & Vision Loss Expert Group of the Global Burden of Disease, S","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jconrel.2025.114027_bb0010","first-page":"6","volume":"36","author":"FDA approves hereditary blindness gene therapy","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114027_bb0015","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1038\/s41467-024-51575-4","article-title":"Interim safety and efficacy of gene therapy for RLBP1-associated retinal dystrophy: a phase 1\/2 trial","volume":"15","author":"Kvanta","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114027_bb0020","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0140-6736(24)02812-5","article-title":"Gene therapy in children with AIPL1-associated severe retinal dystrophy: an open-label, first-in-human interventional study","volume":"405","author":"Michaelides","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.114027_bb0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2013 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114027_bb0030","article-title":"Delivery of mRNA vaccine with a lipid-like material potentiates antitumor efficacy through toll-like receptor 4 signaling","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114027_bb0035","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/mt.2014.133","article-title":"A cationic nanoemulsion for the delivery of next-generation RNA vaccines","volume":"22","author":"Brito","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114027_bb0040","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","article-title":"Current clinical applications of in vivo gene therapy with AAVs","volume":"29","author":"Mendell","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114027_bb0045","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.114027_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100970","article-title":"Prospects for the application of Muller glia and their derivatives in retinal regenerative therapies","volume":"85","author":"Eastlake","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2025.114027_bb0055","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2122168120","article-title":"Direct neuronal reprogramming by temporal identity factors","volume":"120","author":"Boudreau-Pinsonneault","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114027_bb0060","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41586-020-2975-4","article-title":"Reprogramming to recover youthful epigenetic information and restore vision","volume":"588","author":"Lu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114027_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.755544","article-title":"In vivo regeneration of ganglion cells for vision restoration in mammalian retinas","volume":"9","author":"Xiao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2025.114027_bb0070","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1167\/iovs.19-27184","article-title":"Glaucoma-associated mutations in the Optineurin gene have limited impact on Parkin-dependent Mitophagy","volume":"60","author":"Chernyshova","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2025.114027_bb0075","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41591-020-0763-1","article-title":"Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR","volume":"26","author":"Cehajic-Kapetanovic","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.114027_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2025.102470","article-title":"Human cone photoreceptor transplantation stimulates remodeling and restores function in AIPL1 model of end-stage Leber congenital amaurosis","volume":"20","author":"Procyk","year":"2025","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.jconrel.2025.114027_bb0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-vision-102016-061413","article-title":"Vectors and gene delivery to the retina","volume":"3","author":"Planul","year":"2017","journal-title":"Annu Rev Vis Sci"},{"key":"10.1016\/j.jconrel.2025.114027_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107638","article-title":"From bench to bedside: developing CRISPR\/Cas-based therapy for ocular diseases","volume":"213","author":"Zhao","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2025.114027_bb0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.crvi.2014.01.002","article-title":"Gene therapy for inherited retinal degenerations","volume":"337","author":"Dalkara","year":"2014","journal-title":"C. R. Biol."},{"key":"10.1016\/j.jconrel.2025.114027_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.13.7.7","article-title":"Lipid nanoparticle-mediated delivery of mRNA into the mouse and human retina and other ocular tissues","volume":"13","author":"Chambers","year":"2024","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.jconrel.2025.114027_bb0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jconrel.2019.06.042","article-title":"Non-viral delivery of chemically modified mRNA to the retina: subretinal versus intravitreal administration","volume":"307","author":"Devoldere","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114027_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add4623","article-title":"Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates","volume":"9","author":"Herrera-Barrera","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.114027_bb0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2019.04.015","article-title":"Lipid nanoparticles for delivery of messenger RNA to the back of the eye","volume":"303","author":"Patel","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114027_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241006","article-title":"The effects of PEGylation on LNP based mRNA delivery to the eye","volume":"15","author":"Ryals","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.114027_bb0125","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1038\/s41467-023-42189-3","article-title":"Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina","volume":"14","author":"Gautam","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114027_bb0130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307813120","article-title":"Thiophene-based lipids for mRNA delivery to pulmonary and retinal tissues","volume":"121","author":"Eygeris","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114027_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202400815","article-title":"Preformed vesicle approach to LNP manufacturing enhances retinal mRNA delivery","volume":"20","author":"Eygeris","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.114027_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113900","article-title":"Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across","volume":"176","author":"Minnaert","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114027_bb0145","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.114027_bb0150","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.omtn.2019.08.001","article-title":"Expression kinetics and innate immune response after electroporation and LNP-mediated delivery of a self-amplifying mRNA in the skin","volume":"17","author":"Huysmans","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jconrel.2025.114027_bb0155","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1038\/s41467-020-17409-9","article-title":"Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice","volume":"11","author":"McKay","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114027_bb0160","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ymthe.2021.04.001","article-title":"A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice","volume":"29","author":"de Alwis","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114027_bb0165","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1016\/j.vaccine.2022.03.064","article-title":"A self-amplifying RNA vaccine protects against SARS-CoV-2 (D614G) and alpha variant of concern (B.1.1.7) in a transmission-challenge hamster model","volume":"40","author":"Frise","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.114027_bb0170","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ymthe.2022.01.001","article-title":"A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models","volume":"30","author":"Maruggi","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114027_bb0175","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2022.11.022","article-title":"Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines","volume":"353","author":"Kim","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114027_bb0180","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1038\/s41467-023-38457-x","article-title":"saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern","volume":"14","author":"Komori","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114027_bb0185","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jconrel.2024.12.003","article-title":"Enhancing protective immunity against SARS-CoV-2 with a self-amplifying RNA lipid nanoparticle vaccine","volume":"378","author":"Lin","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114027_bb0190","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/s41467-025-55843-9","article-title":"Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label phase I study in healthy volunteers","volume":"16","author":"Maine","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114027_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114204","article-title":"Less is more: self-amplifying mRNA becomes self-killing upon dose escalation in immune-competent retinal cells","volume":"196","author":"Vanluchene","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.114027_bb0200","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1021\/acsnano.9b01774","article-title":"The skin you are in: design-of-experiments optimization of lipid nanoparticle self-amplifying RNA formulations in human skin explants","volume":"13","author":"Blakney","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114027_bb0205","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41434-019-0095-2","article-title":"Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA","volume":"26","author":"Blakney","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2025.114027_bb0210","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.114027_bb0215","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1073\/pnas.0910603106","article-title":"Lipid-like materials for low-dose, in vivo gene silencing","volume":"107","author":"Love","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114027_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202310623","article-title":"Combinatorial screening of Biscarbamate Ionizable lipids identifies a low Reactogenicity lipid for lipid nanoparticle mRNA delivery","volume":"34","author":"De Lombaerde","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.114027_bb0225","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA","volume":"15","author":"Baiersdorfer","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jconrel.2025.114027_bb0230","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ymthe.2021.01.023","article-title":"Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs","volume":"29","author":"Zhong","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114027_bb0235","first-page":"864","article-title":"In vitro characterization of a spontaneously immortalized human Muller cell line (MIO-M1)","volume":"43","author":"Limb","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2025.114027_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071672","article-title":"MMP2 modulates inflammatory response during axonal regeneration in the murine visual system","volume":"10","author":"Andries","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2025.114027_bb0245","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1523\/JNEUROSCI.0831-09.2009","article-title":"Excitotoxic death of retinal neurons in vivo occurs via a non-cell-autonomous mechanism","volume":"29","author":"Lebrun-Julien","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114027_bb0250","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1167\/iovs.18-25372","article-title":"Longitudinal in vivo characterization of the Streptozotocin-induced diabetic mouse model: focus on early inner retinal responses","volume":"60","author":"Sergeys","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2025.114027_bb0255","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40478-020-01102-5","article-title":"The app(NL-G-F) mouse retina is a site for preclinical Alzheimer\u2019s disease diagnosis and research","volume":"9","author":"Vandenabeele","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jconrel.2025.114027_bb0260","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/joa.13889","article-title":"Hyper-reflective dots in optical coherence tomography imaging and inflammation markers in diabetic retinopathy","volume":"243","author":"Mat Nor","year":"2023","journal-title":"J. Anat."},{"key":"10.1016\/j.jconrel.2025.114027_bb0265","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/IAE.0b013e31826710ea","article-title":"Intravitreal cellular infiltrate imaged as punctate spots by spectral-domain optical coherence tomography in eyes with posterior segment inflammatory disease","volume":"33","author":"Saito","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.jconrel.2025.114027_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111825","article-title":"MMP-3 deficiency alleviates endotoxin-induced acute inflammation in the posterior eye segment","volume":"17","author":"Van Hove","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114027_bb0275","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s40265-018-0983-6","article-title":"First global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2025.114027_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202310623","article-title":"Combinatorial Screening of Biscarbamate Ionizable Lipids Identifies a Low Reactogenicity Lipid for Lipid Nanoparticle mRNA Delivery","volume":"34","author":"De Lombaerde","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.114027_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100915","article-title":"Immune responses to retinal gene therapy using adeno-associated viral vectors \u2013 implications for treatment success and safety","volume":"83","author":"Bucher","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2025.114027_bb0290","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/glia.23875","article-title":"Tightening the retinal glia limitans attenuates neuroinflammation after optic nerve injury","volume":"68","author":"Lefevere","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.jconrel.2025.114027_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.997786","article-title":"Microglia morphophysiological diversity and its implications for the CNS","volume":"13","author":"Vidal-Itriago","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114027_bb0300","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.preteyeres.2018.12.002","article-title":"Immune cells in the retina and choroid: two different tissue environments that require different defenses and surveillance","volume":"70","author":"McMenamin","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2025.114027_bb0305","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fncel.2020.00198","article-title":"Overview of general and discriminating markers of differential microglia phenotypes","volume":"14","author":"Jurga","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114027_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116550","article-title":"Microglia in retinal diseases: from pathogenesis towards therapeutic strategies","volume":"230","author":"Xiao","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.114027_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","article-title":"Glia-neuron interactions in the mammalian retina","volume":"51","author":"Vecino","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2025.114027_bb0320","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: a bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114027_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/biom13060901","article-title":"The role of retinal pigment epithelial cells in age-related macular degeneration: phagocytosis and autophagy","volume":"13","author":"Si","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2025.114027_bb0330","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1523\/JNEUROSCI.22-21-09228.2002","article-title":"Microglia-Muller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration","volume":"22","author":"Harada","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114027_bb0335","article-title":"Muller glia in retinal development: from specification to circuit integration","volume":"15","author":"Tworig","year":"2021","journal-title":"Front Neural Circuits"},{"key":"10.1016\/j.jconrel.2025.114027_bb0340","doi-asserted-by":"crossref","first-page":"28311","DOI":"10.1021\/acsnano.4c09677","article-title":"Amplification of protein expression by self-amplifying mRNA delivered in lipid nanoparticles containing a beta-Aminoester Ionizable lipid correlates with reduced innate immune activation","volume":"18","author":"De Lombaerde","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114027_bb0345","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.2217\/nnm.12.202","article-title":"Measuring the intravitreal mobility of nanomedicines with single-particle tracking microscopy","volume":"8","author":"Martens","year":"2013","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2025.114027_bb0350","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","article-title":"Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo","volume":"167","author":"Xu","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114027_bb0355","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.exer.2014.07.014","article-title":"Extracellular matrix in the trabecular meshwork: intraocular pressure regulation and dysregulation in glaucoma","volume":"133","author":"Vranka","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2025.114027_bb0360","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2017.09.007","article-title":"In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye","volume":"126","author":"Peynshaert","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114027_bb0365","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/02713683.2019.1565890","article-title":"Morphology and composition of the inner limiting membrane: species-specific variations and relevance toward drug delivery research","volume":"44","author":"Peynshaert","year":"2019","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2025.114027_bb0370","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jconrel.2020.10.028","article-title":"Ocular barriers to retinal delivery of intravitreal liposomes: impact of vitreoretinal interface","volume":"328","author":"Tavakoli","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114027_bb0375","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejpb.2019.05.023","article-title":"The obstacle course to the inner retina: hyaluronic acid-coated lipoplexes cross the vitreous but fail to overcome the inner limiting membrane","volume":"141","author":"Devoldere","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.114027_bb0380","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jconrel.2022.07.002","article-title":"ICG-mediated photodisruption of the inner limiting membrane enhances retinal drug delivery","volume":"349","author":"Peynshaert","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114027_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081716","article-title":"Photodisruption of the inner limiting membrane: exploring ICG loaded nanoparticles as photosensitizers","volume":"14","author":"De Clerck","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114027_bb0390","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2024.08.016","article-title":"The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNA","volume":"374","author":"Barbieri","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114027_bb0395","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"Muller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2025.114027_bb0400","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.preteyeres.2009.07.001","article-title":"Cellular signaling and factors involved in Muller cell gliosis: neuroprotective and detrimental effects","volume":"28","author":"Bringmann","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2025.114027_bb0405","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.drudis.2019.01.023","article-title":"Muller cells as a target for retinal therapy","volume":"24","author":"Devoldere","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2025.114027_bb0410","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12951-022-01478-7","article-title":"Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects","volume":"20","author":"Kiaie","year":"2022","journal-title":"J Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114027_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091973","article-title":"Immune responses to gene editing by viral and non-viral delivery vectors used in retinal gene therapy","volume":"14","author":"Ren","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114027_bb0420","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jconrel.2025.114027_bb0425","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154-155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114027_bb0430","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nbt1402","article-title":"A combinatorial library of lipid-like materials for delivery of RNAi therapeutics","volume":"26","author":"Akinc","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114027_bb0435","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1002\/anie.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"51","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem. Int. Ed. Eng."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925006480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925006480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:15:58Z","timestamp":1778944558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925006480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":87,"alternative-id":["S0168365925006480"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114027","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy versus immunogenicity of LNP-mediated delivery of mRNA and self-amplifying RNA upon intravitreal injection in the mouse eye","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114027"}}